| 2005 | Telemedicine with digital video transport system in Asia -Pacific area | 문병인 | Conference Paper |
| 2011 | The 70-gene prognostic signature for korean breast cancer patients | 문병인 | Article |
| 2012 | The association of type D personality with anticipatory nausea/vomiting in breast cancer patients receiving chemotherapy in a university hospital | 임원정; 문병인; 임우성; 백남선; 최희연 | Meeting Abstract |
| 2009 | The breast and ovarian cancer risks in Korea due to inherited mutations in BRCA1 and BRCA2: A preliminary report | 문병인 | Article |
| 2010 | The change of practice patterns of the hereditary breast cancer management in korea after the korean hereditary breast cancer study [Korean Source] | 문병인 | Article |
| 2021 | The comparison of breast reconstruction using two types of acellular dermal matrix after breast-conserving surgery | 문병인; 임우성; 백남선; 권형주; 안정신 | Article |
| 2008 | The current status of endoscopic thyroidectomy in Korea | 문병인 | Article |
| 2018 | The effect of adjuvant chemotherapy on survival in Korean patients with node negative t1c, triple negative breast cancer | 문병인 | Article |
| 2017 | The effect of reproductive factors on breast cancer presentation in women who are BRCA mutation carrier | 문병인 | Article |
| 2015 | The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study | 문병인 | Article |
| 2013 | The prevalence of BRCA mutations among familial breast cancer patients in Korea: Results of the Korean Hereditary Breast Cancer study | 문병인 | Article |
| 2008 | The role and significance of preoperative breast MRI in the setting of breast cancer | 문병인 | Article |
| 2016 | The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress | 문병인 | Article |
| 2008 | The use of an in vitro adenosine triphosphate-based chemotherapy response assay to predict chemotherapeutic response in breast cancer | 한운섭; 성순희; 문병인 | Article |
| 2016 | The value of cytoplasmic Y-box-binding protein 1 as a prognostic marker for breast cancer in Korean | 서주영; 성순희; 문병인; 임우성; 박희정; 우주현 | Article |
| 2007 | Toxicity of concurrent adjuvant CMF chemotherapy and radiotherapy in patients with early breast cancer | 최금자; 최혜영; 문병인; 서현숙; 최국진 | Article |
| 2022 | Treatment Outcomes according to the EndoPredict Score in ER-Positive, HER2-Negative Early Breast Cancer | 문병인; 김규보; 정원근 | Article |
| 2016 | Two-year Follow-up of Volumetric-modulated Arc Therapy for Treating Internal Mammary Nodes in Locally Advanced Breast Cancer | 문병인; 이레나; 임우성; 백남선; 김규보; 이지혜 | Article |
| 2018 | Use of CA15-3 for screening breast cancer: An antibody-lectin sandwich assay for detecting glycosylation of CA15-3 in sera | 문병인; 이준우 | Article |
| 2016 | Variability of Ki67 labeling index depending on different measurements in luminal type breast cancers | 문병인 | Meeting Abstract |
| 2014 | Zonal difference and prognostic significance of Foxp3 regulatory T cell infiltration in breast cancer | 구혜수; 성순희; 문병인; 조민선; 임우성; 박상희 | Article |
